Editas Medicine Inc (EDIT)
1.195
-0.02
(-1.24%)
USD |
NASDAQ |
Dec 26, 11:54
Editas Medicine Free Cash Flow: -191.36M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ionis Pharmaceuticals Inc | -374.21M |
| EyePoint Pharmaceuticals Inc | -118.04M |
| Cassava Sciences Inc | -78.07M |
| Adverum Biotechnologies Inc | -86.06M |
| Regenxbio Inc | -184.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -52.59M |
| Cash from Investing (Quarterly) | 83.98M |
| Free Cash Flow Per Share (Quarterly) | -0.673 |
| Free Cash Flow to Equity (Quarterly) | -55.51M |
| Free Cash Flow Yield | -195.0% |